Efficacy and safety of 5 mg daily dosing regimens with linagliptin in patients with type 2 diabetes inadequately controlled on metformin

被引：0
|
作者：
Rafeiro, E. [1 ]
Ross, S. A. [2 ]
Meinicke, T. [3 ]
Toorawa, R. [4 ]
Woerle, H. -J. [5 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Burlington, ON, Canada
[2] Univ Calgary, LMC Endocrinol Ctr, Calgary, AB T2N 1N4, Canada
[3] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[4] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[5] Boehringer Ingelheim KG, D-6507 Ingelheim, Germany
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
831
引用
收藏
页码：S338 / S339
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Linagliptin in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
    Taskinen, Marja-Riitta
    Rosenstock, Julio
    Tamminen, Ilkka
    Kubiak, Rene
    Patel, Sanjay
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    [J]. DIABETES, 2010, 59 : A158 - A158
  • [2] Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial
    Ross, Stuart A.
    Rafeiro, Elizabeth
    Meinicke, Thomas
    Toorawa, Robert
    Weber-Born, Sonja
    Woerle, Hans-Juergen
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (09) : 1465 - 1474
  • [3] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Magner, J
    Taylor, T
    Krol, A
    Rosenstock, J
    [J]. DIABETOLOGIA, 1998, 41 : A231 - A231
  • [4] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, J
    Magner, J
    Krol, A
    Taylor, T
    [J]. DIABETES, 1998, 47 : A351 - A351
  • [5] Linagliptin provides similar efficacy but with glimepiride improves cardiovascular safety to 2 years in Patients with Type 2 diabetes inadequately controlled with metformin
    Sloan, L.
    Newman, J.
    Sauce, C.
    von Eynatten, M.
    Patel, S.
    Woerle, H. J.
    Katsadze, V.
    [J]. DIABETES & METABOLISM, 2012, 38 : A102 - A102
  • [6] Efficacy and Safety of Initial Combination Therapy with Linagliptin and Pioglitazone in Patients with Inadequately Controlled Type 2 Diabetes
    Gomis, Ramon
    Espadero, Rosa-Maria
    Jones, Russell
    Woerle, Hans-Juergen
    Dugi, Klaus A.
    [J]. DIABETES, 2010, 59 : A150 - A150
  • [7] Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Gao, Yan
    Yoon, Kun Ho
    Chuang, Lee-Ming
    Mohan, Viswanathan
    Ning, Guang
    Shah, Sanjiv
    Jang, Hak Chul
    Wu, Ta-Jen
    Johns, Don
    Northrup, Justin
    Brodows, Robert
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 69 - 76
  • [8] Safety and efficacy of linagliptin as add-on therapy to a sulphonylurea in inadequately controlled type 2 diabetes
    Lewin, A. J.
    Arvay, L.
    Liu, D.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETOLOGIA, 2010, 53
  • [9] Efficacy and safety of linagliptin in Asian patients with type 2 diabetes mellitus inadequately controlled by metformin: A multinational 24-week, randomized clinical trial
    Wang, Weiqing
    Yang, Jinkui
    Yang, Gangyi
    Gong, Yan
    Patel, Sanjay
    Zhang, Candice
    Izumoto, Toshiyasu
    Ning, Guang
    [J]. JOURNAL OF DIABETES, 2016, 8 (02) : 229 - 237
  • [10] Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin
    Rodbard, H. W.
    Seufert, J.
    Aggarwal, N.
    Cao, A.
    Fung, A.
    Pfeifer, M.
    Alba, M.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 812 - 819
12345